

"The liver has strong regenerative ability," said Taniguchi, a 49-year-old transplant surgeon who has long faced a serious shortage of living liver donors. "I think our techniques will become applicable to human patients within 10 years," he said, anticipating a particularly strong impact on the treatment of newborn babies with severe hepatitis.
(Jiji Press)